Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
Most models to predict biochemical recurrence (BCR) of prostate cancer use pretreatment serum prostate-specific antigen (PSA), clinical stage and prostate biopsy Gleason grade. We investigated whether human glandular kallikrein 2 (hK2) and free prostate-specific antigen (fPSA) measured in pretreatme...
Main Authors: | Steuber, T, Vickers, A, Haese, A, Becker, C, Pettersson, K, Chun, F, Kattan, M, Eastham, J, Scardino, P, Huland, H, Lilja, H |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2006
|
פריטים דומים
-
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
מאת: Haese, A, et al.
יצא לאור: (2001) -
Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues.
מאת: Olsson, A, et al.
יצא לאור: (2005) -
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
מאת: Steuber, T, et al.
יצא לאור: (2007) -
The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.
מאת: Becker, C, et al.
יצא לאור: (2001) -
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
מאת: Haese, A, et al.
יצא לאור: (2003)